Elevated Donor Troponin Levels Are Associated with a Lower Frequency of Allograft Vasculopathy

Elevated donor troponin levels are not associated with the development of CAV but rather with a significantly reduced long-term risk of developing CAV, suggesting a possible protective effect of donor released protein.